RecruitingNCT02143986
Glycosylated Ferritin in Macrophagic Activation Syndromes
Studying Adult-onset Still disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brugmann University Hospital
- Enrollment
- 60 enrolled
- Eligibility
- 85 years · All sexes
- Timeline
- 2014 – 2030
Study locations (1)
- Brugmann University Hospital, Brussels, Belgium
Collaborators
Université Libre de Bruxelles
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02143986 on ClinicalTrials.govOther trials for Adult-onset Still disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07203001A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's DiseaseNovartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE3NCT05814159A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)Swedish Orphan Biovitrum
- RECRUITINGNCT04402086Rheumatology Patient Registry and BiorepositoryYale University
- RECRUITINGNCT03510442Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- RECRUITINGNCT05927454Acostill ( RaDiCo Cohort) (RaDiCo Acostill)Institut National de la Santé Et de la Recherche Médicale, France